🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This non-interventional study aims to observe the effect of early versus la...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2023-07-10
Trial ID
NCT05776888
Treatments Being Tested
This study is a single-country, non-interventional, multicenter, observatio...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2024-12-10
Trial ID
NCT06486779
Treatments Being Tested
This study aims to assess whether, and the degree to which, ofatumumab modu...
Status
Enrolling By Invitation
Location
Johns Hopkins
Start Date
2023-05-22
Trial ID
NCT06167642
Treatments Being Tested
Study to evaluate the effectiveness of ofatumumab in Italian RRMS patients ...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2024-07-30
Trial ID
NCT06345157
Treatments Being Tested
This real-life study aims to describe IgG levels after switching from ocrel...
Status
Not Yet Recruiting
Location
CHU de Lille
Start Date
2026-06
Trial ID
NCT07625800
Treatments Being Tested
The study is an observational retrospective cohort study using longitudinal...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2024-06-30
Trial ID
NCT06156683
Treatments Being Tested
This study aims to generate real-world evidence on the clinical effectivene...
Status
Recruiting
Location
Novartis
Start Date
2026-04-08
Trial ID
NCT07779460
The purpose of this trial is to investigate the efficacy (how well the drug...
Status
Completed
Location
Saint Francis Medical Center
Start Date
2010-03-29
Trial ID
NCT01060384
Treatments Being Tested
This phase II trial studies the side effects and how well combination chemo...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2017-08-09
Trial ID
NCT03136146
The nature, intensity, and prevalence of this wearing-off effect remain poo...
Status
Completed
Location
Novartis Investigative Site
Start Date
2023-12-04
Trial ID
NCT06121349
Treatments Being Tested